AGO2 Antikörper
(1 reference)-
- Target Alle AGO2 Antikörper anzeigen
- AGO2 (Argonaute 2 (AGO2))
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser AGO2 Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (IHC)
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Affinity purification
- Immunogen
- A synthetic peptide of human Argonaute-2 (NP_036286.2).
- Isotyp
- IgG
- Top Product
- Discover our top product AGO2 Primärantikörper
-
anti-Argonaute 2 (AGO2) (AA 1-377) antibody
AGO2 Reaktivität: Human WB, ELISA, IF, IHC (p), RNAi Wirt: Maus Monoclonal 2E12-1C9 unconjugated
anti-Argonaute 2 (AGO2) (AA 517-818) antibodyAGO2 Reaktivität: Human WB, ELISA, IHC, ChIP Wirt: Kaninchen Polyclonal unconjugated
anti-Argonaute 2 (AGO2) (AA 1-100) antibodyAGO2 Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Argonaute 2 (AGO2) (AA 27-59), (N-Term) antibodyAGO2 Reaktivität: Human WB, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB8013 unconjugated
anti-Argonaute 2 (AGO2) (N-Term) antibodyAGO2 Reaktivität: Human, Maus, Ratte WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Argonaute 2 (AGO2) (AA 47-115) antibodyAGO2 Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Argonaute 2 (AGO2) (AA 1-377) antibodyAGO2 Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
anti-Argonaute 2 (AGO2) (AA 381-480) antibodyAGO2 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 2H2 unconjugated
-
- Applikationshinweise
- IHC 1:50-1:200
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
: "Targeting a novel circITCH/miR-421/BTG1 axis is effective to suppress the malignant phenotypes in hepatocellular carcinoma (HCC) cells." in: Cytotechnology, Vol. 75, Issue 3, pp. 255-267, (2023) (PubMed).
-
: "Targeting a novel circITCH/miR-421/BTG1 axis is effective to suppress the malignant phenotypes in hepatocellular carcinoma (HCC) cells." in: Cytotechnology, Vol. 75, Issue 3, pp. 255-267, (2023) (PubMed).
-
- Target
- AGO2 (Argonaute 2 (AGO2))
- Andere Bezeichnung
- Argonaute-2 (AGO2 Produkte)
- Hintergrund
- This gene encodes a member of the Argonaute family of proteins which play a role in RNA interference. The encoded protein is highly basic, and contains a PAZ domain and a PIWI domain. It may interact with dicer1 and play a role in short-interfering-RNA-mediated gene silencing. Multiple transcript variants encoding different isoforms have been found for this gene.
- Gen-ID
- 27161
- UniProt
- Q9UKV8
- Pathways
- Fc-epsilon Rezeptor Signalübertragung, Regulatorische RNA Pathways, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Ribonucleoprotein Complex Subunit Organization
-
